TRAWS PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.653 USD | +2.08% |
|
+0.45% | -12.42% |
| May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
| Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 13.49M | - | - | - | |||
| 54.04B | - | |||||
| 41.96B | ||||||
| 41.92B | ||||||
| 28.35B | ||||||
| 26.35B |
- Stock Market
- Equities
- TRAW Stock
- Charts Traws Pharma, Inc.
- Sector Chart